PRC1 and neoplasm: Furthermore, ANLN, ASPM, CDCA5, CENPF, FOXM1, KIAA0101, MELK, NDC80, PRC1, RACGAP1, SPAG5, and TPX2, which play important roles in tumor progression, metastasis, DNA damage repair, and hematopoiesis, are associated with poor outcomes and tumor stage [167].